Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Perrigo Company Stories

2013-01-31 12:28:00

ALLEGAN, Mich., Jan. 31, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on March 19, 2013 to shareholders of record on March 1, 2013. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) From its beginnings as a packager of generic home remedies in 1887, Perrigo Company, based in Allegan, Michigan, has grown to become a leading global provider of quality, affordable...

2013-01-24 08:31:28

ST. LOUIS, Jan. 24, 2013 /PRNewswire/ -- Ther-Rx Corporation, a women's health-focused pharmaceutical company and subsidiary of K-V Pharmaceutical Company (OTCQB Marketplace: KVPHA/KVPHB), and Perrigo Company (Nasdaq: PRGO; TASE) announced today that Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%), indicated for the local treatment of yeast infections (vulvovaginal candidiasis infections caused by Candida) in non-pregnant women(1), is now available for prescribing. Gynazole-1...

2013-01-22 08:31:15

ALLEGAN, Mich., Jan. 22, 2013 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor). (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) This launch represents the first to market nicotine mini lozenge products for the store brand market. The mint flavored mini lozenges are marketed under retailer and wholesalers' store, or own...

2013-01-18 12:22:34

ALLEGAN, Mich., Jan. 18, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE:) today announced that it will release financial results for its second quarter fiscal year 2013 on Friday, February 1, 2013 at approximately 8:00 a.m. (ET). The Company will conduct a conference call at 10:00 a.m. (ET) hosted by Joseph C. Papa, Perrigo's Chairman, President and Chief Executive Officer. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO) The conference call will be available live...

2013-01-15 12:27:59

ALLEGAN, Mich., Jan. 15, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq® Foam, consistent with the date certain launch settlement previously announced. Cobrek Pharmaceuticals, Inc. ("Cobrek"), which was recently acquired by Perrigo, was first to file, making the product eligible for 180 days of marketing exclusivity. Perrigo is entitled to receive 100% of...

2013-01-07 08:30:18

ALLEGAN, Mich., Jan. 7, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has made initial shipments distributing Cumberland Pharmaceuticals Inc.'s ("Cumberland") Authorized Generic form of Acetadote® (acetylcysteine) injection. The Authorized Generic is free of EDTA and any other chelating, stabilization or preservative agents. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO) On November 13, 2012, Perrigo announced that it and Cumberland...

2013-01-07 08:30:09

ALLEGAN, Mich., Jan. 7, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that its infant formula division has gained FDA clearance to manufacture three new infant formula products. These new formulas are also compliant with the Codex Alimentarius Commission, established by the Food and Agriculture Organization of the United Nations (FAO) and the World Health Organization (WHO) to set international food standards, guidelines and codes of practice to protect the health...

2013-01-02 16:22:17

ALLEGAN, Mich., Jan. 2, 2013 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the J.P. Morgan 31(st) Annual Healthcare Conference on Monday, January 7, 2013 at the Westin St. Francis Hotel in San Francisco, CA. Interested parties can access the presentation, which is scheduled to begin at 9:30 AM PST, at http://perrigo.investorroom.com/events-webcasts. (Logo:...

2012-12-28 12:22:19

ALLEGAN, Mich., Dec. 28, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharmaceuticals, Inc. (Cobrek), a privately-held, Chicago, Illinois-based drug development company, for approximately $45 million on a cash free and debt free basis. (Logo: http://photos.prnewswire.com/prnh/20120301/DE62255LOGO ) In May 2008, Perrigo acquired an 18.5% minority stake in Cobrek in...

2012-12-04 16:26:51

ALLEGAN, Mich., Dec. 4, 2012 /PRNewswire/ -- The Perrigo Company (Nasdaq: PRGO;TASE) today announced the appointment of Douglas Boothe as Executive Vice President and General Manager, Perrigo Pharmaceuticals, effective January 2013. Sharon Kochan, who previously held this position, has been managing the business in the interim since accepting the newly created role of Executive Vice President and General Manager, International in July 2012. (Logo:...